Kimberly Scardino - Walgreens Boots President

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>WB</div>
WBA -- USA Stock  

 Earnings Call 

  President
Ms. Kimberly R. Scardino is no longer Senior Vice President, Chief Accounting Officer, Global Controller of the Company effective December 21, 2018. Previously, she served American Express Company and its subsidiaries in roles of increasing responsibility, including as Senior Vice President, Business Advisory Controller from March 2015 to July 2015, Senior Vice President, Americas Controller from June 2012 to March 2015, Vice President and Chief Accounting Officer of American Express Credit Corporationration from December 2009 to June 2012, and Vice President, Global Head of SOX Compliance. Prior to joining American Express in 2006, Ms. Scardino served in accounting functions at Credit Suisse from 2004 to 2006 and at Lyondell Chemical Company from 2002 to 2004. Ms. Scardino started her career at Arthur Andersen LLP, where she was an auditor from 1994 to 2002.
Age: 45  President Since 2015      
847 315-2500  www.walgreensbootsalliance.com

Walgreens Boots Management Efficiency

Walgreens Boots Alli has Return on Asset of 7.0E-4 % which means that on every $100 spent on asset it made $7.0E-4 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.0014 % implying that it generated $0.0014 on every 100 dollars invested. Walgreens Boots management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Walgreens Boots Return on Investment is expected to slightly decrease based on the last few years of reporting. The last year's Return on Investment was at 10.78. The current year Return on Average Assets is expected to grow to 7.32, whereas Return on Average Equity is expected to decline to 14.17. Walgreens Boots Total Assets are expected to significantly increase based on the last few years of reporting. The last year's Total Assets were at 60.84 Billion. The current year Current Assets is expected to grow to about 25.9 B, whereas Revenue to Assets are expected to decline to 1.73. Walgreens Boots Liabilities Non Current is expected to significantly increase based on the last few years of reporting. The last year's Liabilities Non Current was at 22.85 Billion. The current year Tax Liabilities is expected to grow to about 2.8 B, whereas Total Liabilities is expected to decline to about 36.6 B.
The company has 17.93 B in debt with debt to equity (D/E) ratio of 74.2 . This implies that the company may be unable to create cash to meet all of its financial commitments. Walgreens Boots Alli has Current Ratio of 0.72 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Stephanie LundquistTarget
2019
James ComitaleRite Aid
2015
Donald GrimesSally Beauty Holdings
2016
Erik KeptnerRite Aid
2019
Rebeckah LongSpectrum Brands Holdings
2019
Joel GradeSysco
2015
Jeff HarkinsSally Beauty Holdings
2017
Carrie McDermottSally Beauty Holdings
2006
Sharon LeiteSally Beauty Holdings
2016
Enio MontiniRite Aid
N/A
Steve RempelRite Aid
2015
Brent BaxterSally Beauty Holdings
2017
Arthur ValdezTarget
2016
Jason GoldbergerTarget
2016
Bryan EverettRite Aid
2019
Jocelyn KonradRite Aid
2019
Paul MoskowitzSysco
2015
Greg BertrandSysco
2018
Don LiuTarget
2017
Heather PlutinoSally Beauty Holdings
2019
Anne DamentTarget
2015

Company Summary

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois. Walgreens Boots operates under Pharmaceutical Retailers classification in USA and is traded on BATS Exchange. It employs 232000 people.Walgreens Boots Alliance (WBA) is traded on BATS Exchange in USA and employs 232,000 people.

Walgreens Boots Alli Leadership Team

Alexander Gourlay, Executive VP and President of Walgreens Co
James Skinner, Executive Chairman
David Brailer, Independent Director
Leonard Schaeffer, Independent Director
Nancy Schlichting, Independent Director
Dominic Murphy, Director
Jan Reed, Senior Vice President General Counsel, Corporatye Secretary
James Kehoe, Global CFO, Executive Vice President - Global
Anthony Roberts, Senior Vice President Global CIO
Marco Pagni, Executive Vice President Global Chief Legal and Administrative Officer
John Lederer, Director
Ken Murphy, Executive Vice President of Walgreens Boots Alliance and Presidentident of Global Brands
Stefano Pessina, Executive Vice Chairman and CEO
Simon Roberts, Executive Vice President of Walgreens Boots Alliance and President of Boots
Gerald Gradwell, IR Contact Officer
Heather Dixon, Senior Vice President Chief Accounting Officer, Global Controller
Kimberly Scardino, Senior Vice President Chief Accounting Officer, Global Controller
Kathleen WilsonThompson, Executive Vice President Global Chief Human Resources Officer
Jeffrey Berkowitz, Executive Vice President of Walgreens Boots Alliance and Presidentident of Pharma and Global Market Access
Ornella Barra, Executive Vice President of Walgreens Boots Alliance and Presidentident and Chief Executive of Global Wholesale and International Retail
Barry Rosenstein, Independent Director
Jose Almeida, Director
Janice Babiak, Independent Director
William Foote, Lead Independent Director
Ginger Graham, Independent Director
George Fairweather, Global CFO and Executive VP

Stock Performance Indicators

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Also Currentnly Active

<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:0.9em;padding-top: 12px;;'>FOR</div>
Purchased over 500 shares of
few hours ago
Traded for 5.9
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:0.9em;padding-top: 12px;;'>SON</div>
Purchased over 40 shares of
few hours ago
Traded for 66.75
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;padding-top: 10px;;'>AL</div>
Purchased few shares of
few hours ago
Traded for 1439.22
Check out Your Current Watchlist. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page